Canadian Consortium on Neurodegeneration in Aging (CCNA) – Launch of Expression of Interest(2013-03-28) CIHR and its partners are pleased to announce the launch of the Canadian Consortium on Neurodegeneration in Aging (CCNA) Expression of Interest. As a dynamic research enterprise, the CCNA will be the premier research hub for all aspects of research involving neurodegenerative diseases that affect cognition in aging – including Alzheimer’s disease. The CCNA is the Canadian component of CIHR’s International Collaborative Research Strategy for Alzheimer’s Disease.
Research within the CCNA will be organized around three themes: primary prevention – aimed at preventing the disease from developing; secondary prevention – focused on delaying the clinical manifestations of the already developing disease; and quality of life – designed for helping individuals, caregivers and the health system in the context of a clinically developed disease.
Applicants are expected to submit an Expression of Interest that describes the whole Consortium including components of training, ethics, legal, and social implications. Applicants are also expected to expand on knowledge translation, shared resources, governance, as well as the teams planned within each theme of the Consortium with their research program.
How can I be part of the CCNA?
CIHR has put in place a number of engagement activities to ensure interested researchers and partners have the opportunity to signal their interest in participating in the CCNA.
- Expression of interest – deadline May 21st, 2013
- Online information sessions (webinars) – April 2013
- Partners’ Forum – August 28-29, 2013 in Montreal
- Online tools for researchers to signal their interest in participating
The deadline for submission of the full application will be December 2nd, 2013. Funding is expected to start in April, 2014.
For more information about the CCNA, please contact:
Canadian Institutes of Health Research - Institute of Aging
- Date modified: